Aviram Mizrachi
Overview
Explore the profile of Aviram Mizrachi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
620
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yosefof E, Edri N, Ben-Nachum I, Yaniv D, Mizrachi A, Asher N, et al.
Oncologist
. 2025 Mar;
30(2).
PMID: 40037617
Background: Programmed-cell death protein 1 (PD-1) inhibitors have emerged as a standard of care treatment among advanced-stage or metastatic cutaneous squamous cell carcinoma (cSCC). Immune-compromised patients and particularly solid organ...
2.
Yosefof E, Edri N, Kurman N, Bachar G, Shpitzer T, Mizrachi A, et al.
Head Neck
. 2025 Jan;
PMID: 39890747
Background: The role of post-operative radiotherapy (PORT) in early-stage (T1-T2N0M0) oral tongue squamous cell carcinoma (OTSCC) with minor adverse features (MAF) including perineural invasion (PNI) and poorly differentiated carcinoma (PDC)...
3.
Ritter A, Reuven Y, Tsur N, Dudkiewicz D, Mizrachi A, Shpitzer T, et al.
Eur Arch Otorhinolaryngol
. 2024 Dec;
PMID: 39702807
Objective: Few studies have reported risk factors for post-thyroidectomy hypoparathyroidism (HPT) in children. We aimed to identify predicting factors for transient and permanent HPT after total thyroidectomy in pediatric patients....
4.
Edri N, Dudkiewicz D, Yaniv D, Ritter A, Strenov Y, Mizrachi A, et al.
Head Neck
. 2024 Oct;
47(3):856-866.
PMID: 39474634
Background: Depth of invasion (DOI) has a significant clinical impact on the staging system of oral squamous cell carcinoma (OSCC). We aimed to compare the prognostic impact of treating DOI...
5.
Winder O, Lazar L, Hod R, Shpitzer T, Mizrachi A, Bachar G
Laryngoscope
. 2024 Oct;
134(11):4818-4825.
PMID: 39387721
Objectives: Differentiated thyroid cancer (DTC) is rare in the pediatric population. It remains unclear whether younger children are at greater risk of more aggressive disease. We aimed to identify prognostic...
6.
Levin E, Ritter A, Amitai A, Shpitzer T, Bachar G, Mizrachi A, et al.
Acta Otorhinolaryngol Ital
. 2024 Sep;
44(4):214-222.
PMID: 39347546
Objective: The study aimed to identify factors affecting the management and prognosis of iatrogenic cervical oesophageal and hypopharyngeal perforations (iCEHPs). Methods: We retrospectively analysed 24 patients treated for iCEHP between...
7.
Yaniv D, Flukes S, Livneh N, Vainer I, Soudry E, Amitai N, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274356
: Endoscopic endonasal skull base surgery has become a viable alternative to open procedures for the surgical treatment of benign and malignant lesions in the sinonasal and skull base regions....
8.
Dudkiewicz D, Yosefof E, Shpitzer T, Mizrachi A, Yehuda M, Shoffel-Havakuk H, et al.
Laryngoscope
. 2024 Sep;
135(1):161-167.
PMID: 39230351
Objective: The traditional categorical division of surgical margins using a 5 mm cutoff in oral cavity squamous cell carcinoma (OCSCC) is controversial. The primary aim of this study was to...
9.
Levin E, Ritter A, Bachar G, Mizrachi A, Shoffel-Havakuk H, Kurman N, et al.
Head Neck
. 2024 Aug;
47(1):300-308.
PMID: 39138648
Background: Laryngeal chondroradionecrosis (LCRN) is a rare but severe complication of radiation therapy. The study aimed to review the management of LCRN and evaluate the clinical benefit of hyperbaric oxygen...
10.
Popovtzer A, Mizrachi A, DAndrea M, VanderWalde N, Kurman N, Rosenfeld E, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001374
The initial favorable efficacy and safety profile for Alpha DaRT have been demonstrated (NCT04377360); however, the longer-term safety and durability of the treatment are unknown. This pooled analysis of four...